alexef03.bsky.social
@alexef03.bsky.social
February 8, 2026 at 5:19 PM
In our new Antibiotics Deconstructed column, authors discuss the recently approved intravenous fosfomycin (Contepo), with an overview of the therapeutic including its mechanism of action, data, availability, and prospective costs. #IDsky #Medsky
Antibiotics Deconstructed: IV Fosfomycin | Contagion Live
The FDA recently approved intravenous fosfomycin (Contepo), which is a new option for adults with complicated urinary tract infections, including those caused by resistant Gram-negative pathogens. Her...
www.contagionlive.com
February 8, 2026 at 5:19 PM
Macrolide and non-macrolide resistance after 36 months of mass azithromycin distribution in Burkina Faso: A cluster randomized trial

✅ Just Accepted
🔗 https://bit.ly/4rAQP9u
February 8, 2026 at 5:18 PM
This week, listen in on commentary around the ongoing measles outbreak, read our new Antibiotics Deconstructed column on IV fosfomycin, review data on metformin preventing long COVID, insights on diagnostic stewardship, and more.
Top Infectious Disease News Stories Week of February 1 - February 7 | Contagion Live
This week, listen in on commentary around the ongoing measles outbreak, read our new Antibiotics Deconstructed column on IV fosfomycin, review data on metformin preventing long COVID, insights on dia...
www.contagionlive.com
February 8, 2026 at 5:18 PM